These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8191397)

  • 1. A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol).
    Pattacini C; Manotti C; Pini M; Quintavalla R; Dettori AG
    Thromb Haemost; 1994 Feb; 71(2):188-91. PubMed ID: 8191397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).
    Cosmi B; Palareti G; Carpanedo M; Pengo V; Biasiolo A; Rampazzo P; Morstabilini G; Testa S
    Haematologica; 2000 Aug; 85(8):826-31. PubMed ID: 10942929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of the stability of oral anticoagulant treatments (warfarin vs acenocoumarol)].
    Amián A; Rodríguez JN; Muñiz R; Diéguez JC; Moreno MV; Quesada JA; Cañavate M; Fernández-Jurado A; Martino ML; Prados D
    Sangre (Barc); 1996 Feb; 41(1):9-11. PubMed ID: 8779047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low incidence of hemorrhagic complications of oral anticoagulant therapy in patients with atrial fibrillation in the daily practice of an anticoagulation clinic.
    Poli D; Antonucci E; Lombardi A; Cecchi E; Corsini I; Gensini GF; Abbate R; Prisco D
    Ital Heart J; 2003 Jan; 4(1):44-7. PubMed ID: 12690920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
    Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks factors for highly unstable response to oral anticoagulation: a case-control study.
    Palareti G; Legnani C; Guazzaloca G; Lelia V; Cosmi B; Lunghi B; Marchetti G; Poli D; Pengo V;
    Br J Haematol; 2005 Apr; 129(1):72-8. PubMed ID: 15801958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term application of warfarin or acenocumarol in patients with fibrillating arrhythmia: the effects compared].
    Kropacheva ES; Panchenko EP; Ataullakhanova DM
    Klin Med (Mosk); 2005; 83(1):24-7. PubMed ID: 15759486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Laboratory and therapeutic control of oral anticoagulant treatment].
    Salvetti E; Molinatti M
    Ann Osp Maria Vittoria Torino; 1987-1988; 30():67-71. PubMed ID: 3508666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment with oral anticoagulants (acenocoumarol): influence of the initial doses in the incidence of hemorrhagic and thromboembolic episodes].
    Amian A; Rodríguez JN; Muñiz R; Diéguez JC; Cañavate M; Fernández-Jurado A; Martino ML; Prados D
    Sangre (Barc); 1994 Dec; 39(6):413-6. PubMed ID: 7855691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between thrombophilic genetic mutations and clinical bleeding in patients on chronic oral anticoagulant treatment.
    Castori L; Taliani MR; Agnelli G; Boschetti E; Gresele P
    Haematologica; 2005 Dec; 90(12):1720-2. PubMed ID: 16330459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparin (nadroparine) versus oral anticoagulant (acenocoumarol) in the long-term treatment of deep venous thrombosis: comparison of efficacy, safety and hospitalisation period in 105 patients.
    Mazokopakis EE; Vrentzos GE; Ganotakis ES
    Curr Med Res Opin; 2003; 19(6):565-6. PubMed ID: 14594529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases].
    Katona A; Márk L
    Orv Hetil; 2004 Aug; 145(32):1643-7. PubMed ID: 15384862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia.
    Nicolini A; Ghirarduzzi A; Iorio A; Silingardi M; Malferrari G; Baldi G
    Haematologica; 2002 Sep; 87(9):948-56. PubMed ID: 12217807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of thromboembolism with short-term interruption of warfarin therapy.
    Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
    Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence and quality of anticoagulant treatment of chronic atrial fibrillation in primary health care in Sweden: a retrospective study on electronic patient records.
    Nilsson GH; Björholt I
    BMC Clin Pharmacol; 2004 Feb; 4():1. PubMed ID: 15028124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemorrhagic incidents during prolonged ambulatory treatment with acenocoumarol].
    Reverter JC; Tàssies D; Maragall S; Monteagudo J; Escolar G; Ordinas A
    Med Clin (Barc); 1995 Jun; 105(4):127-30. PubMed ID: 7623503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.